Literature DB >> 9613982

Sea-blue histiocyte syndrome in bone marrow secondary to total parenteral nutrition.

C Bigorgne1, A Le Tourneau, K Vahedi, B Rio, B Messing, T Molina, J Audouin, J Diebold.   

Abstract

Clinical and hematological abnormalities can occur in patients receiving intravenous fat emulsions as part of a long-term parenteral nutrition; they consist of hepatosplenomegaly and peripheral blood cytopenia(s). These abnormalities lead to bone marrow examination which revealed numerous macrophages laden with blue staining pigment granules and separate lipid vacuoles, presenting the typical histochemical characteristics of sea-blue histiocytes. Thus, long-term parenteral nutrition including fat-emulsion sources may represent a further condition in addition to the wide variety of disorders which can be associated with sea-blue histiocytosis. Moreover, in view of its clinical and morphological presentation, this storage pathological state could be compared with the so-called sea-blue histiocyte syndrome described by Silverstein and colleagues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613982     DOI: 10.3109/10428199809058360

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

1.  Fish Oil Lipid Emulsion-Associated Sea-Blue Histiocyte Syndrome in a Pediatric Patient.

Authors:  Ting Ting Wu; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

Review 2.  Abnormal liver function tests in the parenteral nutrition fed patient.

Authors:  S M Gabe; A Culkin
Journal:  Frontline Gastroenterol       Date:  2010-06-15

3.  Copper deficiency-related bone marrow changes secondary to long-term total parenteral nutrition.

Authors:  Thein Hlaing Oo; Shimin Hu
Journal:  Clin Case Rep       Date:  2016-12-29

4.  Post-Chemotherapy Foamy Histiocytes in Bone Marrow Aspiration of a Child with Acute Lymphoblastic Leukemia

Authors:  Moeinadin Safavi; Zohreh Nozarian; Farzad Kompani
Journal:  Turk J Haematol       Date:  2021-01-14       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.